VentureLabs alumni company, Aspect Biosystems raises US$115 million Series B financing
Aspect Biosystems successfully raised US$115 million Series B financing to proceed with bioprinted tissue therapeutics development. Aspect Biosystems is a biotechnology company that is developing technology to help incurable diseases…
VentureLabs company closes a $11.5 Million Series A Funding Round
Spexi raised USD 11.5 million in a Series A funding round with lead investor Blockchange Ventures. This milestone follows their seed round in 2022 and they have since expanded to…
VentureLabs alumni receives $20M from the US Department of Energy
Moment Energy was awarded USD $20.3 million by the US Department of Energy (DOE) to establish the first UL1974-certified EV battery repurposing facility in the US. The Gigafactory will be…
SFU VentureLabs Member Companies to Attend HealthTech Ignite Conference
FOR IMMEDIATE RELEASE October 10, 2024 Vancouver, BC — SFU VentureLabs is excited to announce three member companies will attend HealthTech Ignite, an annual conference presented by Pender Ventures. This…
SFU VentureLabs Gives Out Prizes to Emerging Startups at Annual New Ventures BC Competition
FOR IMMEDIATE RELEASE September 19, 2024 Vancouver, BC —The vibrant provincial startup and innovation scene was in full swing at the New Ventures BC Competition awards ceremony on Thursday night,…
SFU VentureLabs Company, Spexi, To Speak Alongside City of Vancouver at Conference in Whistler
FOR IMMEDIATE RELEASE September 9, 2024 Vancouver, BC — SFU VentureLabs company, Spexi, is set to speak alongside the City of Vancouver on September 11th as part of the MISA…
Topics
Tags
Events
Capital Raising Essentials for Entrepreneurs
BDC Square Suite 1500 (15th Floor) 1133 Melville Street Vancouver27
Contact Us
Ready to start a conversation?
Get in touch with us.